MedTrace Logo

Clinical and Molecular Characterization of Cerebral Proliferative Vasculopathy

NCT03293134 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2017-09-26

No results posted yet for this study

Summary

As principal objective, the study aims to:

1. Describe the spectrum and evaluate the frequency of angiodysplasia of the nevrax;
2. Establish the physiopathological basis of Fowler's syndrome;
3. Identify FLVCR2 partners and the signaling pathways involved;
4. Test new candidate genes: GPR124 and possible partners of FLVCR2.

As second objective, the study aims to:

* perform phenotype / genotype correlation if necessary;
* and propose a prenatal diagnosis in families with identified mutations.

Conditions

  • Proliferative Vasculopathy

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Tania Attié-Bitach, MD, PhD · Hôpital Necker Enfants Malades, APHP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-08
Primary Completion
2015-03-09
Completion
2016-10-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03293134 on ClinicalTrials.gov